Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development.
Liu Y, Xu Z, Hu L, Xia L, Li Q, Zhou W, Chen Y, Li W, Jiang W, Zhu X, Gao X, Xia Y, Zhu Z, Chen S, Ding CZ.
Liu Y, et al. Among authors: li w, li q.
Bioorg Med Chem Lett. 2024 Nov 1;112:129941. doi: 10.1016/j.bmcl.2024.129941. Epub 2024 Sep 1.
Bioorg Med Chem Lett. 2024.
PMID: 39222890